英文名稱 Anti-BCAS2

中文名稱 乳腺癌相關(guān)蛋白2抗體

濃 度 1mg/1ml

規(guī) 格 0.1ml/100μg 0.2ml/200μg

抗體來源 Rabbit

克隆類型 polyclonal

交叉反應(yīng) Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse,Sheep

產(chǎn)品類型 一抗

研究領(lǐng)域 腫瘤 細(xì)胞生物 腫瘤細(xì)胞生物標(biāo)志物 表觀遺傳學(xué)

蛋白分子量 predicted molecular weight: 26kDa

性 狀 Lyophilized or Liquid

免 疫 原 KLH conjugated synthetic peptide derived from humanBCAS2 (162-210aa)

亞 型 IgG

純化方法 affinity purified by Protein A

儲(chǔ) 存 液 Preservative: 15mM Sodium Azide, Constituents: 1%BSA, 0.01M PBS, pH 7.4

產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)）

not yet tested in other applications.

optimal dilutions/concentrations should be determined by theend user.

保存條件 Store at -39 °C for oneyear.

別 名 DNA amplified in mammary carcinoma 1 protein;Spliceosome associated protein SPF 27; bcas2; Breast carcinoma amplifiedsequence 2; Breast carcinoma-amplified sequence 2; DAM1; MGC7712; Pre mRNAsplicing factor SPF27; Pre-mRNA-splicing factor spf27; SPF27_HUMAN; Spliceosomeassociated protein amplified in breast cancer; Spliceosome-associated proteinSPF 27.